![Ross Moat](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ross Moat
Geen lopende functies
Vermogen: 581 963 $ op 31-05-2026
Profiel
Ross Moat currently works at Kiniksa Pharmaceuticals Ltd. as Chief Commercial Officer & Senior Vice President since 2022.
Mr. Moat also works at Kiniksa Pharmaceuticals International Plc as Chief Operating Officer & Executive Vice President starting in 2026.
Former roles include General Manager at Synageva BioPharma Corp.
and VP-EMEA Marketing & Commercial Operations at Novartis Gene Therapies, Inc. from 2018 to 2019.
Education includes an undergraduate degree from Middlesex University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
0,03% | 09-04-2026 | 12.029 ( 0,03% ) | 581 963 $ | 31-05-2026 |
Actieve functies van Ross Moat
| Bedrijven | Functie | Begin |
|---|---|---|
Kiniksa Pharmaceuticals Ltd.
 Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Corporate Officer/Principal | 01-02-2021 |
Eerdere bekende functies van Ross Moat
| Bedrijven | Functie | Einde |
|---|---|---|
| AVEXIS INC | Verkoop & Marketing | 01-06-2019 |
| SYNAGEVA BIOPHARMA CORP | Corporate Officer/Principal | - |
Opleiding van Ross Moat
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
16
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Middlesex University
 Middlesex University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage gene therapy company | Health Technology |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Health Technology |
